Anticancer activities of a benzimidazole compound through sirtuin inhibition in colorectal cancer

Yi Jer Tan1, Yeuan Ting Lee1, Keng Yoon Yeong1,2

  • 1Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang, 11800, Malaysia.

Abstract

Insights

A novel sirtuin inhibitor, BZD9L1, effectively reduced colorectal cancer (CRC) cell viability and migration by inducing apoptosis. This compound shows promise as a colorectal cancer therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Colorectal cancer (CRC) remains a significant global health challenge.
  • Targeted therapies are crucial for improving CRC treatment outcomes.
  • Sirtuin inhibitors represent a potential new class of anticancer agents.

Purpose of the Study:

  • To elucidate the mechanism of action of a novel sirtuin inhibitor, BZD9L1.
  • To investigate the molecular pathways affected by BZD9L1 in colorectal cancer (CRC) cells.
  • To evaluate the therapeutic potential of BZD9L1 in CRC.

Main Methods:

  • Cytotoxicity assays were performed on metastatic CRC cell lines (HCT 116, HT-29).
  • Cell cycle progression, apoptosis, and senescence were analyzed.
  • Expression of apoptosis-related genes and proteins was assessed.
  • Impact on major cancer signaling pathways was evaluated.

Main Results:

  • BZD9L1 significantly reduced viability, migration, and colony formation in CRC cells.
  • Apoptosis was identified as the primary mechanism of BZD9L1-induced cell death.
  • BZD9L1 modulated cancer signaling pathways differently based on CRC mutation profiles.
  • The inhibitor demonstrated cytotoxic effects against metastatic CRC cell lines.

Conclusions:

  • BZD9L1 exhibits potent anticancer activities in colorectal cancer.
  • BZD9L1 induces apoptosis and inhibits key cancer hallmarks in CRC cells.
  • BZD9L1 represents a promising therapeutic strategy for colorectal cancer treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.2K
Molecules and Compounds02:38

Molecules and Compounds

Atoms and Molecules
68.9K
Organic Compounds03:02

Organic Compounds

All living things are formed mostly of carbon compounds called organic compounds. The category of organic compounds includes both natural and synthetic compounds that contain carbon. Although a single, precise definition has yet to be identified by the chemistry community, most agree that a defining trait of organic molecules is the presence of carbon as the principal element, bonded to hydrogen and other carbon atoms. However, some carbon-containing compounds such as carbonates, cyanides, and...
57.5K
Elements and Compounds01:27

Elements and Compounds

Pure substances consist of only one type of matter. A pure substance can be an element or a compound. An element consists of only one type of atom, while a compound consists of two or more types of atoms held together by a chemical bond.
Elements
Elements are classified as atomic or molecular based on the nature of their basic units. They are unique forms of matter with specific chemical and physical properties that cannot break down into smaller substances by ordinary chemical reactions. There...
105.0K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.6K